Cubist Systematic Strategies LLC Sells 46,541 Shares of Seer, Inc. (NASDAQ:SEER)

Cubist Systematic Strategies LLC lessened its position in Seer, Inc. (NASDAQ:SEER) by 61.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,737 shares of the company’s stock after selling 46,541 shares during the period. Cubist Systematic Strategies LLC’s holdings in Seer were worth $66,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Renaissance Technologies LLC grew its position in shares of Seer by 27.0% in the 4th quarter. Renaissance Technologies LLC now owns 843,700 shares of the company’s stock valued at $1,949,000 after acquiring an additional 179,568 shares during the period. Bridgeway Capital Management LLC grew its position in shares of Seer by 17.6% in the 4th quarter. Bridgeway Capital Management LLC now owns 727,743 shares of the company’s stock valued at $1,681,000 after acquiring an additional 109,000 shares during the period. Peapod Lane Capital LLC bought a new position in shares of Seer in the 4th quarter valued at about $991,000. JPMorgan Chase & Co. grew its position in shares of Seer by 67.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 175,354 shares of the company’s stock valued at $345,000 after acquiring an additional 70,671 shares during the period. Finally, Northern Trust Corp grew its position in shares of Seer by 48.7% in the 4th quarter. Northern Trust Corp now owns 155,617 shares of the company’s stock valued at $359,000 after acquiring an additional 50,992 shares during the period. Institutional investors own 75.20% of the company’s stock.

Seer Price Performance

Shares of SEER opened at $2.07 on Tuesday. The firm has a 50-day moving average of $1.92 and a 200-day moving average of $2.17. Seer, Inc. has a one year low of $1.56 and a one year high of $2.63. The company has a market cap of $123.75 million, a PE ratio of -1.59 and a beta of 1.58.

Seer (NASDAQ:SEER) last announced its earnings results on Tuesday, May 13th. The company reported ($0.34) EPS for the quarter, topping the consensus estimate of ($0.37) by $0.03. The business had revenue of $4.21 million during the quarter, compared to the consensus estimate of $3.25 million. Seer had a negative net margin of 565.83% and a negative return on equity of 21.96%. Analysts expect that Seer, Inc. will post -1.42 earnings per share for the current year.

Seer Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.